BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

Westport, CT, May 21, 2024 -- BioSig Technologies, Inc. , a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, has today issued the...

Related Keywords

Anthony Amato ,Globenewswire Inc ,Nasdaq Panel ,Nasdaq ,Biosig Or Company ,Biosig Technologies Inc ,Nasdaq Hearings Panel ,Exchange Commission ,Biomedical Signal Processing Technology ,While The Company ,Sig Technologies ,Corporate Governance ,Advisory Board ,Biomedical Signal Processing ,Artificial Intelligence ,Hearings Panel ,Nasdaq Listing Qualifications ,Listing Rule ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Quarterly Report ,Amato Chief Executive Officer ,